RadNet Share Holder Equity 2010-2024 | RDNT

RadNet share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
RadNet Annual Share Holder Equity
(Millions of US $)
2023 $813
2022 $491
2021 $346
2020 $258
2019 $233
2018 $200
2017 $70
2016 $52
2015 $36
2014 $8
2013 $2
2012 $-7
2011 $-70
2010 $-82
2009 $-75
RadNet Quarterly Share Holder Equity
(Millions of US $)
2024-09-30 $1,120
2024-06-30 $1,093
2024-03-31 $1,077
2023-12-31 $813
2023-09-30 $796
2023-06-30 $761
2023-03-31 $493
2022-12-31 $491
2022-09-30 $458
2022-06-30 $451
2022-03-31 $421
2021-12-31 $346
2021-09-30 $339
2021-06-30 $299
2021-03-31 $281
2020-12-31 $258
2020-09-30 $246
2020-06-30 $233
2020-03-31 $207
2019-12-31 $233
2019-09-30 $215
2019-06-30 $212
2019-03-31 $214
2018-12-31 $200
2018-09-30 $121
2018-06-30 $125
2018-03-31 $116
2017-12-31 $70
2017-09-30 $74
2017-06-30 $64
2017-03-31 $53
2016-12-31 $52
2016-09-30 $40
2016-06-30 $37
2016-03-31 $38
2015-12-31 $36
2015-09-30 $26
2015-06-30 $12
2015-03-31 $7
2014-12-31 $8
2014-09-30 $3
2014-06-30 $-3
2014-03-31 $-9
2013-12-31 $2
2013-09-30 $0
2013-06-30 $5
2013-03-31 $2
2012-12-31 $-7
2012-09-30 $-59
2012-06-30 $-65
2012-03-31 $-69
2011-12-31 $-70
2011-09-30 $-76
2011-06-30 $-77
2011-03-31 $-82
2010-12-31 $-82
2010-09-30 $-88
2010-06-30 $-88
2010-03-31 $-79
2009-12-31 $-75
2009-09-30 $-78
2009-06-30 $-77
2009-03-31 $-84
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.764B $1.617B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.312B 0.00
Quest Diagnostics (DGX) United States $18.153B 18.23
DaVita (DVA) United States $14.110B 18.25
Encompass Health (EHC) United States $9.934B 22.26
Chemed (CHE) United States $8.335B 25.62
Elanco Animal Health (ELAN) United States $5.917B 14.08
Option Care Health (OPCH) United States $5.245B 24.85
LifeStance Health (LFST) United States $3.053B 0.00
Amedisys (AMED) United States $3.017B 21.47
Addus HomeCare (ADUS) United States $2.171B 25.48
Astrana Health (ASTH) United States $2.001B 27.37
U.S Physical Therapy (USPH) United States $1.324B 34.81
Aveanna Healthcare Holdings (AVAH) United States $0.935B 0.00
Pennant (PNTG) United States $0.935B 37.81
Atai Life Sciences (ATAI) Germany $0.356B 0.00
Bioqual (BIOQ) United States $0.054B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00